Basic Information
Princeps Therapeutics is developing E3 ligase inhibitors to protect therapeutically valuable proteins from degradation.
Princeps Therapeutics
United States of America
unclear
January 01, 2017
--
--
Enterprise Profile
Industrial Sector
Technology
Application Scenarios